25 Best Dividend Stocks to Buy According to Billionaires

Page 20 of 23

4. Johnson & Johnson (NYSE:JNJ)

Number of Billionaire Investors: 18

Dividend Yield as of March 3: 2.98%

Johnson & Johnson (NYSE:JNJ) ranks fourth on our list of the best dividend stocks according to billionaires. An American pharmaceutical company operates through its subsidiaries to develop, manufacture, and market a wide range of healthcare products.

Renowned for its strong brand and commitment to research, Johnson & Johnson (NYSE:JNJ) has built a reputation for innovation in areas such as immunology, oncology, and surgical technology. The company recently streamlined its operations by spinning off its consumer health segment, Kenvue, allowing it to focus more on its high-margin pharmaceutical and medical technology businesses. With a strong pipeline of new treatments and a resilient business model, JNJ remains a dominant force in the healthcare industry, benefiting from steady demand and long-term demographic trends. It is considered one of the top undervalued global stocks to watch.

In the fourth quarter of 2024, Johnson & Johnson (NYSE:JNJ) reported $22.5 billion in revenue, marking a 5.2% year-over-year increase. As a leading healthcare company, it continues to target diseases with significant unmet medical needs, including multiple myeloma, lung cancer, inflammatory bowel disease, and heart failure. The MedTech division experienced 6.2% global operational sales growth, with acquisitions and divestitures contributing 1.5% to this increase. Rising demand for electrophysiology products and Abiomed supported growth in the Cardiovascular segment, while strong sales of wound closure products bolstered the General Surgery division.

Johnson & Johnson (NYSE:JNJ) currently pays a quarterly dividend of $1.24 per share, offering a 2.98% yield as of March. With an impressive 62-year streak of consecutive dividend increases, the company remains one of the most reliable dividend payers in the market.

Page 20 of 23